{"id":877815,"date":"2025-08-21T07:10:29","date_gmt":"2025-08-21T11:10:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/"},"modified":"2025-08-21T07:10:29","modified_gmt":"2025-08-21T11:10:29","slug":"shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/","title":{"rendered":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Aug. 21, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=144302360&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a> announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" title=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" alt=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p class=\"prntac\">\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=488161815&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=PLEASE+CLICK+HERE+TO+JOIN+THE+CASE+AND+SUBMIT+CONTACT+INFORMATION\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/b><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <b>\u00a0RxSight, Inc. Class Action Lawsuit Summary<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Defendant:<\/b>\u00a0RxSight, Inc. (NASDAQ: RXST)<\/li>\n<li>\n          <b>Class Period:<\/b> Investors who purchased or otherwise acquired RxSight securities within the relevant period of <span class=\"xn-chron\">November 7, 2024<\/span> through <span class=\"xn-chron\">July 8, 2025<\/span>, inclusive, may be eligible.<\/li>\n<li>\n          <b>Allegations:<\/b>\u00a0Securities <span>fraud<\/span> and\/or other unlawful business practices by RxSight and certain officers or directors.<\/li>\n<li>\n          <b>Key Event:<\/b>\n        <\/li>\n<ul type=\"circle\">\n<li>On <b><span class=\"xn-chron\">July 8, 2025<\/span><\/b>, RxSight reported <b>preliminary Q2 2025 results<\/b>, disclosing:<\/li>\n<ul type=\"square\">\n<li>Significant declines in sales of its Light Delivery Device (LDD)<\/li>\n<li>Lower usage of light adjustable intraocular lenses<\/li>\n<li>Overall revenue shortfall<\/li>\n<li>\n              <b>Full year 2025 guidance cut by approximately <span class=\"xn-money\">$42.5 million<\/span><\/b>\u00a0<\/li>\n<\/ul>\n<li>CEO <b><span class=\"xn-person\">Ronald Kurtz<\/span><\/b> cited <i>&#8220;adoption challenges&#8221;<\/i> as a major factor for the sales stall.<\/li>\n<li>Following this news, the stock price dropped <b><span class=\"xn-money\">$4.84<\/span><\/b> (\u221237.84%) to <b><span class=\"xn-money\">$7.95<\/span><\/b> per share on <b><span class=\"xn-chron\">July 9, 2025<\/span><\/b>.<\/li>\n<\/ul>\n<li>\n          <b>Important Deadline:<\/b>\u00a0<b>Lead Plaintiff<\/b> deadline is <b><span class=\"xn-chron\">September 22, 2025<\/span><\/b>. Please contact <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=810644385&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein<\/span><\/a> to learn more about your rights as a shareholder.<\/li>\n<\/ul>\n<p>\n        <b>Why\u00a0<\/b><br \/>\n        <b><br \/>\n          <u><br \/>\n            <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=144302360&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><br \/>\n              <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a><br \/>\n          <\/u><br \/>\n        <\/b><br \/>\n        <b>?<\/b><br \/>\n        <b>:<\/b>\n      <\/p>\n<p>This illustrious <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=388063406&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=firm\" target=\"_blank\" rel=\"nofollow\">firm<\/a>, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements.\u00a0The <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=443633164&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=law+firm%C2%A0b\" target=\"_blank\" rel=\"nofollow\">law firm\u00a0b<\/a>rings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.<\/p>\n<p>We encourage all investors who have been affected or have information that will assist in our investigation, to contact\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=144302360&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a>.<\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Phone:<\/b>\u00a0(800) 575-0735 or (212) 545-4774<\/li>\n<li>\n          <b>Email:\u00a0<\/b><br \/>\n          <a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\">classmember@whafh.com<\/a>\n        <\/li>\n<li>\n          <b>Contact Person:<\/b>\u00a0<a href=\"mailto:gstone@whafh.com\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Gregory Stone<\/span>, Director of Case and Financial Analysis<\/a><\/li>\n<\/ul>\n<p>\n        <b>Firm Website:<\/b>\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492635-3&amp;h=144302360&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a><\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY55971&amp;sd=2025-08-21\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-302535199.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-302535199.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY55971&amp;Transmission_Id=202508210705PR_NEWS_USPR_____NY55971&amp;DateId=20250821\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Aug. 21, 2025 \/PRNewswire\/ &#8212;\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION \u00a0RxSight, Inc. Class Action Lawsuit Summary Defendant:\u00a0RxSight, Inc. (NASDAQ: RXST) Class Period: Investors who purchased or otherwise acquired RxSight securities within the relevant period of November 7, 2024 through July 8, 2025, inclusive, may be eligible. Allegations:\u00a0Securities fraud and\/or other unlawful business practices by RxSight and certain officers or directors. Key Event: On July 8, 2025, RxSight reported preliminary Q2 2025 results, disclosing: Significant &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-877815","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Aug. 21, 2025 \/PRNewswire\/ &#8212;\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION \u00a0RxSight, Inc. Class Action Lawsuit Summary Defendant:\u00a0RxSight, Inc. (NASDAQ: RXST) Class Period: Investors who purchased or otherwise acquired RxSight securities within the relevant period of November 7, 2024 through July 8, 2025, inclusive, may be eligible. Allegations:\u00a0Securities fraud and\/or other unlawful business practices by RxSight and certain officers or directors. Key Event: On July 8, 2025, RxSight reported preliminary Q2 2025 results, disclosing: Significant &hellip; Continue reading &quot;Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-21T11:10:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd\",\"datePublished\":\"2025-08-21T11:10:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/\",\"name\":\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"datePublished\":\"2025-08-21T11:10:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk","og_description":"PR Newswire NEW YORK , Aug. 21, 2025 \/PRNewswire\/ &#8212;\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION \u00a0RxSight, Inc. Class Action Lawsuit Summary Defendant:\u00a0RxSight, Inc. (NASDAQ: RXST) Class Period: Investors who purchased or otherwise acquired RxSight securities within the relevant period of November 7, 2024 through July 8, 2025, inclusive, may be eligible. Allegations:\u00a0Securities fraud and\/or other unlawful business practices by RxSight and certain officers or directors. Key Event: On July 8, 2025, RxSight reported preliminary Q2 2025 results, disclosing: Significant &hellip; Continue reading \"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-21T11:10:29+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd","datePublished":"2025-08-21T11:10:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/","name":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","datePublished":"2025-08-21T11:10:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=877815"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877815\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=877815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=877815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=877815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}